MedTrace Logo

Type 2 Diabetes After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: A Randomised Single Centre Study

NCT01778738 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2023-04-19

No results posted yet for this study

Summary

Glycaemia, insulin secretion and action in morbidly obes subjects with type 2 diabetes after sleeve gastrectomy ond Roux-en-Y gastric bypass: A randomised single centre study.

Conditions

Interventions

PROCEDURE

Bariatric surgery, either gastric bypass surgery or sleeve gastrectomy

Vertical sleeve gastrectomy or a gastric bypass surgery in morbidly obese individuals with type 2 diabetes. Random allocation to surgical intervention

PROCEDURE

Sleeve gastrecomy

Vertical sleeve gastrectomy

PROCEDURE

Bastric bypass

Gastric bypass surgery

Sponsors & Collaborators

  • Sykehuset i Vestfold HF

    lead OTHER

Principal Investigators

  • Jøran Hjelmesæth, Professor · Head of the Morbid Obesity Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2019-01-31
Completion
2022-11-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01778738 on ClinicalTrials.gov